Aligos Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 444.11 K | $2.56 M | 0.00% | 4.26% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 412.00 K | $2.38 M | 0.00% | 3.95% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 327.24 K | $1.89 M | 0.00% | 3.14% |
| MARSHALL WACE, LLP | 08/13/2026 | 246.58 K | $1.42 M | -7.70% | 2.36% |
| WOODLINE PARTNERS LP | 08/14/2026 | 177.36 K | $1.02 M | 0.00% | 1.70% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 175.54 K | $1.01 M | -1.53% | 1.68% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 83.06 K | $479.23 K | 0.00% | 0.80% |
| HHLR ADVISORS, LTD. | 08/14/2026 | 76.25 K | $439.95 K | 0.00% | 0.73% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 66.46 K | $383.49 K | 505.42% | 0.64% |
| UBS GROUP AG | 08/13/2026 | 59.99 K | $346.12 K | 61.86% | 0.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 47.17 K | $272.32 K | -5.61% | 0.45% |
| JANE STREET GROUP, LLC | 08/14/2026 | 32.40 K | $186.96 K | 100.00% | 0.31% |
| BLACKROCK, INC. | 08/07/2026 | 30.29 K | $174.79 K | 132.30% | 0.29% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 28.61 K | $165.09 K | 0.62% | 0.27% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 21.04 K | $121.42 K | 100.00% | 0.20% |
| VERITION FUND MANAGEMENT LLC | 08/14/2026 | 18.89 K | $108.98 K | 0.00% | 0.18% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 12.34 K | $71.20 K | 100.00% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 10.80 K | $62.32 K | -89.25% | 0.10% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 10.00 K | $57.70 K | 0.00% | 0.10% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 4.65 K | $26.83 K | 389.47% | 0.04% |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 07/22/2026 | 2.67 K | $15.43 K | 0.00% | 0.03% |
| ROYAL BANK OF CANADA | 08/14/2026 | 2.13 K | $12.00 K | 0.00% | 0.02% |
| CITIGROUP INC | 08/03/2026 | 1.81 K | $10.43 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 359 | $2.07 K | 452.31% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 344 | $1.87 K | -48.96% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 204 | $1.18 K | -6.42% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 126 | $727 | 384.62% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 100 | $577 | -85.71% | 0.00% |
| FMR LLC | 08/13/2026 | 10 | $58 | 100.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 07/08/2026 | 4 | $24 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 3 | $17 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SUMMITTX CAPITAL, L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Aligos Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Aligos Therapeutics Inc. The most heavily invested institutionals were:
Deep Track Capital, LP: 444,110
Alyeska Investment Group, L.P.: 412,000
Sio Capital Management, LLC: 327,237
MARSHALL WACE, LLP: 246,579
Woodline Partners LP: 177,362
VANGUARD CAPITAL MANAGEMENT LLC: 175,543
21.98% of Aligos Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 5.79 M shares in the last 24 months. This purchase volume represents approximately $40.70 M in transactions.